pasteurella erysipelas vaccine
intervet ireland limited - pasteurella multocida erysipelothrix rhusiopathiae strain m2 (serotype 2) - suspension for injection - fowl - immunological
rhiniseng
laboratorios hipra s.a. - inactivated bordetella bronchiseptica, strain 833cer / recombinant type-d pasteurella-multocida toxin (pmtr) - immunologicals - pigs (gilts and sows) - for the passive protection of piglets via colostrum after active immunisation of sows and gilts to reduce the clinical signs and lesions of progressive and non-progressive atrophic rhinitis, as well as to reduce weight loss associated with bordetella-bronchiseptica and pasteurella-multocida infections during the fattening period. challenge studies have demonstrated that passive immunity lasts until piglets are six weeks of age while in clinical field trials, the beneficial effects of vaccination (reduction in nasal lesion score and weight loss) are observed until slaughter.
apvma veterinary use permit 14397- custom duck riemerella and pasteurella vaccine / ducks / septicemia and localised infections
apvma permit - riemerella anatipestifer+pasteurella multocida - vaccine
tribrissen 80 tablets
intervet australia pty limited - trimethoprim; sulfadiazine - oral tablet - trimethoprim pyrimidine active 80.0 mg/tb; sulfadiazine sulfanyl active 400.0 mg/tb - antibiotic & related - dog | bitch | castrate | puppy - bacterial infection | organisms sensitive to combination of | amoxycillin sensitive bacteria | associated with viral disease | gram negative organisms | gram positive organisms | post parturient bacterial infe | primary bacterial infection | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria
poulvac pabac iv emulsion for injection in chicken, ducks and turkeys.
zoetis ireland limited - pasteurella multocida strain x-73 (serovar 1), inactivated, pasteurella multocida strain p-1059 (serovar 3), inactivated, pasteurella multocida strain p-1662 (serovar 4), inactivated, pasteurella multocida, strain cu (serovar 3x4), inactivated - emulsion for injection - unknown - pasteurella vaccine - fowl - chicken, fowl - duck, fowl - turkey - immunological - inactivated vaccine
vaxxon fc
pacificvet limited - pasteurella multocida (inactivated) - pasteurella multocida (inactivated) 0 vaccine - vaccine
linezolid tablet, film coated
teva pharmaceuticals usa, inc. - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid 600 mg - linezolid tablets are indicated for the treatment of infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. linezolid tablets are not indicated for the treatment of gram-negative infections. it is critical that specific gram-negative therapy be initiated immediately if a concomitant gram-negative pathogen is documented or suspected [see warnings and precautions (5.4) ]. nosocomial pneumonia caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates) or streptococcus pneumoniae [see clinical studies (14) ]. community-acquired pneumonia caused by streptococcus pneumoniae , including cases with concurrent bacteremia, or staphylococcus aureus (methicillin-susceptible isolates only) [see clinical studies (14) ]. complicated skin and skin structure infections, including diabetic foot infections, without concomitant osteomyelitis , caused by staphylococcus aureus (methicillin-susceptible and -resistant isolates), streptococcus py
rhiniffa t suspension for injection
boehringer ingelheim animal health belgium - pasteurella multocida; pasteurella multocida anatoxine; bordetella bronchiseptica - suspension for injection - pasteurella multocida; pasteurella multocida anatoxine; bordetella bronchiseptica - bordetella + pasteurella - pig
parapleuro shield p ormulation: each 2 ml contains: actinobacillus pleuropneumoniae, strain 80-1144 - gli (serotype 1) 21.27 od (600 nm) actinobacillus pleuropneumoniae, strain 81-1319 - gl4 (serotype 5) >i.26 od (600 nm) actinobacillus pleuropneumoniae, strain 5751-7 - gl34 (serotype 7) >i.37 od (600 nm) glaesserella parasuis >i.53 od (600 nm) pasteurella multocida serotype a, strain 169 26.3 x 10°cfu (0.28 ml) solution for injection (im)
elanco philippines, inc.; distributor: elanco philippines, inc. - inactivated actinobacillus pleuropneumoniae , glaesserella parasuis , pasteurella multocida bacterin - solution for injection (im) - ormulation: each 2 ml contains: actinobacillus pleuropneumoniae, strain 80-1144 - gli (serotype 1) 21.27 od (600 nm) actinobacillus pleuropneumoniae, strain 81-1319 - gl4 (serotype 5) >i.26 od (600 nm) actinobacillus pleuropneumoniae, strain 5751-7 - gl34 (serotype 7) >i.37 od (600 nm) glaesserella parasuis >i.53 od (600 nm) pasteurella multocida serotype a, strain 169 26.3 x 10°cfu (0.28 ml)
neumosuin formulation: each 2 ml (dose) contains: pasteurella multocida (type a)... ............ 8 x 10^9 actinobacillus pleuropneumoniae (serotype 2) ............ >1/4 mat titer actinobacillus pleuropneumoniae (serotype 4)............. >1/4 mat titer actinobacillus pleuropneumoniae (serotype 5) ............. > 1/4 mat titer mat - microagglutination test suspension for injection (im)
hipra philippines, inc.; distributor: hipra philippines, inc. - inactivated pasteurella multocida , actinobacillus pleuropneumoniae vaccine (vet.) - suspension for injection (im) - formulation: each 2 ml (dose) contains: pasteurella multocida (type a)... ............ 8 x 10^9 actinobacillus pleuropneumoniae (serotype 2) ............ >1/4 mat titer actinobacillus pleuropneumoniae (serotype 4)............. >1/4 mat titer actinobacillus pleuropneumoniae (serotype 5) ............. > 1/4 mat titer mat - microagglutination test